CG Oncology, Inc.CG Oncology, Inc.CG Oncology, Inc.

CG Oncology, Inc.

No trades
See on Supercharts

Price target

66.750.000.00%
The 8 analysts offering 1 year price forecasts for CGON have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to CGON in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CGON EPS for the last quarter is −0.28 USD despite the estimation of −0.36 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of CG Oncology, Inc. financials and stay on top of what is up with the company.
In the next quarter CG Oncology, Inc. revenue is expected to reach ‪205.40 K‬ USD. Check out CG Oncology, Inc. revenue and earnings and make informed decisions.
According to analysts, CGON price target is 66.75 USD with a max estimate of 86.00 USD and a min estimate of 52.00 USD. Check if this forecast comes true in a year, meanwhile watch CG Oncology, Inc. stock price chart and keep track of the current situation with CGON news and stock market news.
We've gathered opinions of 8 analysts rating CGON stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.